GHRP-2s most clearly established human application is not as a therapy at all it is as a diagnostic provocative agent for growth hormone deficiency
Volcano plots further highlighted the differential protein profiles induced by GLP1/E treatment
In people with type 2 diabetes who also use insulin or insulin-stimulating drugs, such as sulfonylureas, the risk of low blood sugar, also called hypoglycemia, may be increased, so the doses of those medicines may need to be lowered
Regarding liver and kidney damage in MTX treatment, Bedoui stated that MTX hepatotoxicity may occur due to the depletion of folate reserves and MTX-polyglutamate formation in the liver (Reference Bedoui, Guillot and Slambarom41)
Itchiness is rarely listed as a primary side effect of semaglutide-based GLP-1 therapy, yet some patients report skin sensations during treatment
7.3 Treatment strategies Calcium channel blockers and opioid antagonists, such as naltrexone, have shown potential for managing heroin addiction and ischemic stroke (Peyravian et al., 2022)